“There’s not one definition of a specialty drug…specialty drugs have a vague group of criteria that many times isn’t clear. You have to find out how your plan defines specialty drugs. If you find generic drugs on a specialty list, you need the right people by your side to fix that.” — Vinay Patel, founder of Mako-Rx

Patients who receive medical balance bills are ill-prepared to decipher what they’re being billed for and why. If there’s any chronic disease more prevalent than healthcare “pricing toxicity”, we don’t know what that might be. Plenty of us calling for transparency in healthcare throw the term “payment integrity” on the table as often as possible. If we stop talking about it, then the predatory billers win…and we just can’t have that.